Prazitone

drugbox
IUPAC_name = 5-phenyl-5-(piperidin-2-ylmethyl)-1,3-diazinane-2,4,6-trione


width = 200
CAS_number = 2409-26-9
synonyms = Prazitone, AGN-511, 5-Phenyl-5-(2-piperidylmethyl)barbituric acid
ATC_prefix =
ATC_suffix =
PubChem = 3050417
DrugBank =
C=16 | H=19 | N=3 | O=3
molecular_weight = 301.34 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Prazitone (AGN-511) is a barbiturate derivative invented in the 1970s. Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant. [ [http://www.google.com/patents?id=b-srAAAAEBAJ&dq=3806596 Ross Langlands. Method for imparting anti-depressant and/or anxiolytic effects to animals. US Patent 3,806,596] ] The dosage range in humans is around 200-600mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.

References